BECTON DICKINSON & CO·4

Nov 28, 8:24 PM ET

Hickey David 4

4 · BECTON DICKINSON & CO · Filed Nov 28, 2023

Insider Transaction Report

Form 4
Period: 2023-11-26
Hickey David
EVP & President, Life Sciences
Transactions
  • Award

    Stock Appreciation Rights

    2023-11-26+9,2139,213 total
    Exercise: $238.89From: 2024-11-26Exp: 2033-11-26Common Stock (9,213 underlying)
  • Award

    Rights to Common Stock Under Deferred Compensation Plan

    2023-11-26+3,02412,237 total
    Exercise: $238.89Common Stock (3,024 underlying)
  • Award

    Common Stock

    2023-11-26+1,6635,862 total
Footnotes (3)
  • [F1]Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
  • [F2]The stock appreciation rights vest in four annual installments beginning November 26, 2024.
  • [F3]The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES